Literature DB >> 2793886

Aseptic loosening in total hip arthroplasty secondary to osteolysis induced by wear debris from titanium-alloy modular femoral heads.

A V Lombardi1, T H Mallory, B K Vaughn, P Drouillard.   

Abstract

Since 1984, we have used components made of titanium alloy for total joint arthroplasty. Recently, two patients needed revision hip arthroplasty, approximately three years after the initial procedure, because of aseptic loosening secondary to severe osteolysis that had been induced by metallic debris. Although implants made of titanium alloy have many favorable qualities--most importantly, superb biocompatibility--the alloy is more susceptible to wear by particles of acrylic cement and tends to generate more polyethylene wear than do components made of stainless steel or chromium-cobalt. A new process of implanting ions has reportedly improved resistance to wear as well as fatigue properties and has enhanced the resistance to corrosion of the implants. Although, to our knowledge, only in vitro studies of this process have been reported to date, we recommend avoiding the use of components made of titanium alloy in which ions have not been implanted. We suggest considering the possibility of osteolysis secondary to appreciable metallic debris in patients who have aseptic loosening of titanium-alloy components that were not implanted with ions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793886

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  19 in total

1.  Quantifying subtle but persistent peri-spine inflammation in vivo to submicron cobalt-chromium alloy particles.

Authors:  Nadim James Hallab; Frank W Chan; Megan L Harper
Journal:  Eur Spine J       Date:  2012-03-10       Impact factor: 3.134

2.  Quantitative analysis of the wear and wear debris from low and high carbon content cobalt chrome alloys used in metal on metal total hip replacements.

Authors:  J L Tipper; P J Firkins; E Ingham; J Fisher; M H Stone; R Farrar
Journal:  J Mater Sci Mater Med       Date:  1999-06       Impact factor: 3.896

3.  Bearing surfaces in total joint replacement.

Authors:  R B Welch; G Levengood
Journal:  West J Med       Date:  1991-08

4.  Survivorship of 2000 tapered titanium porous plasma-sprayed femoral components.

Authors:  Adolph V Lombardi; Keith R Berend; Thomas H Mallory; Michael D Skeels; Joanne B Adams
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

5.  Assessment of epidural versus intradiscal biocompatibility of PEEK implant debris: an in vivo rabbit model.

Authors:  Nadim J Hallab; Qi-Bin Bao; Tim Brown
Journal:  Eur Spine J       Date:  2013-08-31       Impact factor: 3.134

6.  Impaired Autophagy in the Fibroblasts by Titanium Particles Increased the Release of CX3CL1 and Promoted the Chemotactic Migration of Monocytes.

Authors:  Wen Wu; Lei Wang; Yuan-Qing Mao; Ke-Rong Dai; Yong-Qiang Hao
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

7.  Effects of titanium particle size on osteoblast functions in vitro and in vivo.

Authors:  Moon G Choi; Hae S Koh; Daniel Kluess; Daniel O'Connor; Anshu Mathur; George A Truskey; Janet Rubin; David X F Zhou; K-L Paul Sung
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

8.  [Titanium deposits on the ceramic heads of dislocated total hip replacements].

Authors:  A Schuh; U Holzwarth; W Kachler; J Göske; G Zeiler
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

9.  Effect of particles and interface conditions on fibrous tissue interposition between bone and implant. A particle challenge model in rabbit.

Authors:  H Ohashi; A Kobayashi; Y Kadoya; Y Yamano; H Oonishi; H Iwaki
Journal:  J Mater Sci Mater Med       Date:  2000-04       Impact factor: 3.896

10.  Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements.

Authors:  P A Revell; S E Jellie
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.